Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Jul 24:8:207.
doi: 10.1186/1471-2407-8-207.

ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer

Suzanne K Chambers  1 , Megan Ferguson, R A Gardiner, David Nicol, Louisa Gordon, Stefano Occhipinti, Joanne Aitken
Affiliations
Randomized Controlled Trial

ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer

Suzanne K Chambers et al. BMC Cancer. .

Abstract

Background: Prostate cancer is the most common male cancer in the Western world but is highly heterogeneous in disease progression and outcomes. Consequently, the most substantial morbidity may actually arise from the adverse psychosocial impact of distress in decision-making and long term quality of life effects such as impotence. This paper presents the design of a randomised controlled trial of a decision support/psychosocial intervention for men newly diagnosed with localised prostate cancer.

Methods/design: 350 men per condition (700 men in total) have been recruited after diagnosis and before treatment through urology private practices and hospital outpatient clinics and randomised to 1) a tele-based nurse delivered five session decision support/psychosocial intervention or 2) a usual care control group. Two intervention sessions are delivered before treatment that address decision support, stress management and preparation for treatment. Three further sessions are provided three weeks, seven weeks and five months after treatment that focus on adjustment to cancer, problem solving and coping with treatment side effects. Participants are assessed at baseline (before treatment) and 2, 6, 12, 24 and 36 months post-treatment. Outcome measures include: cancer threat appraisal; decision-related distress and bother from treatment side effects; involvement in decision making; satisfaction with health care; heath care utilisation; use of health care resources; and a return to previous activities.

Discussion: The study will provide recommendations about the efficacy of early decision support to facilitate adjustment after prostate cancer. As well the study will identify men diagnosed with localised prostate cancer at risk of poorer long term psychosocial adjustment.

Trial registration: ACTRN012607000233426.

PubMed Disclaimer

References

    1. Baade PD, Youlden D, Krnjacki L. International epidemiology of prostate cancer: geographical distribution and secular trends. Molecular Nutrition and Food Research. 2008. p. In Press . - PubMed
    1. Abbas F, Scardino PT. The natural history of clinical prostate carcinoma. Cancer. 1997;80:827–833. doi: 10.1002/(SICI)1097-0142(19970901)80:5<827::AID-CNCR1>3.0.CO;2-I. - DOI - PubMed
    1. Australian Cancer Network Working Party on Management of Localised Prostate Cancer . Clinical Practice Guidelines: Evidence-based information and recommendations for the management of localised prostate cancer. Canberra , National Health and Medical Research Council; 2002. pp. 1–137.
    1. Burger M, Steginga SK, Williams S, Gardiner RA. Prostate Cancer. In: McLachlan R, editor. Endotextcom 'Your Endocrine Source': Endocrinology of Male Reproduction. 2006. p. Chapter 10.http://www.endotext.org/male/index.htm
    1. Steginga SK, Occhipinti S. The Application of the Heuristic Systematic Processing Model to Treatment Decision Making about Prostate Cancer. Medical Decision Making. 2004;24:573–583. doi: 10.1177/0272989X04271044. - DOI - PubMed

Publication types